Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Anthocyanin effects on microglia M1/M2 phenotype: Consequence on neuronal fractalkine expression.
Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
[Knowing more about oneself to help one care for others].
'The worm that got away': parainfectious atypical optic neuritis associated with schistosomiasis infection.
Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
Investigation-Directed Approach to Inflammatory Optic Neuropathies.
Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.
Microglia - performers of the 21st century.
[Clinical and magnetic resonance imaging features of neuromyelitis optics with positive anti-nuclear antibody serum].
Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.
AQP4 autoantibody assay performance in clinical laboratory service.
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
Helicobacter pylori and autoimmune disease: Cause or bystander.
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation.
Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
Increased multiple sclerosis relapses related to lower prevalence of pain.
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.
Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review.
Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter.

Pages